ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      59,951.48
      1.21%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. AbbVie Inc (ABBV)

      7. AbbVie Inc (ABBV) News

      ABBV

      AbbVie (ABBV)

      AbbVie Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ABBV
      DateTimeSourceHeadlineSymbolCompany
      03/20/20205:35PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NYSE:ABBVAbbVie Inc
      03/20/20204:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      03/20/202011:17AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      03/19/202011:19AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      03/18/202010:43AMDow Jones NewsForm 8.3 - [Allergan plc ]NYSE:ABBVAbbVie Inc
      03/17/20204:30PMPR Newswire (US)AbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending TransactionNYSE:ABBVAbbVie Inc
      03/16/202010:48AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
      03/13/202010:23AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
      03/12/202011:03AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      03/12/20207:00AMPR Newswire (US)AbbVie Receives European Commission Approval of VENCLYXTO® Combination Regimen for Patients with Previously-Untreated Chroni...NYSE:ABBVAbbVie Inc
      03/11/20201:07PMPR Newswire (Canada)AbbVie annonce l'inscription de SKYRIZI® à d'autres listes de médicaments pour le traitement du psoriasis en plaques modé...NYSE:ABBVAbbVie Inc
      03/11/20201:07PMPR Newswire (Canada)AbbVie Announces New Formulary Listings for SKYRIZI® in the Treatment of Moderate to Severe Plaque PsoriasisNYSE:ABBVAbbVie Inc
      03/11/202010:52AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
      03/10/202010:48AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
      03/09/20205:19PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:ABBVAbbVie Inc
      03/09/202011:47AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
      03/09/20209:54AMDow Jones NewsAbbVie Says It Can't Confirm Reports About Efficacy Of Drug In Treating CoronavirusNYSE:ABBVAbbVie Inc
      03/09/20209:45AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
      03/09/20209:36AMPR Newswire (US)AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan NotesNYSE:ABBVAbbVie Inc
      03/09/20208:45AMPR Newswire (US)AbbVie Partnering with Global Authorities to Determine Efficacy of HIV Drug in Treating COVID-19NYSE:ABBVAbbVie Inc
      03/09/20207:43AMDow Jones NewsBristol Myers Phase 3 Empliciti Study Misses Primary EndpointNYSE:ABBVAbbVie Inc
      03/06/202010:14AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
      03/06/20207:43AMDow Jones NewsAbbVie Gets European Commission Approval to Shorten Maviret RegimenNYSE:ABBVAbbVie Inc
      03/06/20207:00AMPR Newswire (US)European Commission Grants AbbVie Marketing Authorization Shortening MAVIRET® (glecaprevir/pibrentasvir) Treatment Duration ...NYSE:ABBVAbbVie Inc
      03/05/202010:35AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
      03/04/20205:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      03/04/20209:59AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
      03/03/20204:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      03/03/20204:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      03/03/20204:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
       Showing the most relevant articles for your search:NYSE:ABBV